Penumbra, Inc.
- PEN
- NYSE
- Medical devices
- Thrombectomy Devices
- Vascular/Neurovascular Medical Devices
$320.86
Today −0.11%Quote Oct 16, 2026, 08:00 PM UTC
+0.62%over the last month
Max drawdown −1.1%From 1-month high −0.1%3 months +0.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$12.64B
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$320.00
−0.3% from here
Floor
$318.81
0.6% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PENPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q3 2023 revenue $270.9M
- Neuro$171.4M63.3%
- Peripheral Vascular$99.5M36.7%
Industry
Medical devices
Employees
4,700
Founded
2004